Tony di Pietro
Director/Board Member bij BARD1AG SA
Vermogen: 2 214 $ op 29-02-2024
Profiel
Anthony Salvatore di Pietro occupies the position of Secretary & Director at BARD1AG SA. He is also Member of Australian Institute of Co. Directors and Member of Governance Institute of Australia Ltd.
He previously was Chief Financial Officer & Secretary at Genetic Technologies Ltd., Head-Investor Relations at Acrux Ltd.
and Chief Financial Officer & Joint Secretary at INOVIQ Ltd.
and Chief Financial Officer & Secretary at Sienna Cancer Diagnostics Ltd.
(a subsidiary of INOVIQ Ltd.).
He received an undergraduate degree from Swinburne University of Technology.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
INOVIQ LTD
0.01% | 30-06-2022 | 5 000 ( 0.01% ) | 2 214 $ | 29-02-2024 |
Actieve functies van Tony di Pietro
Bedrijven | Functie | Begin |
---|---|---|
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Corporate Officer/Principal | - |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
BARD1AG SA
BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Director/Board Member | - |
Eerdere bekende functies van Tony di Pietro
Bedrijven | Functie | Einde |
---|---|---|
GENETIC TECHNOLOGIES LIMITED | Director of Finance/CFO | 25-03-2024 |
INOVIQ LTD | Director of Finance/CFO | 02-11-2022 |
ACRUX LIMITED | Director of Finance/CFO | 29-09-2014 |
SIENNA CANCER DIAGNOSTICS LIMITED | Director of Finance/CFO | - |
Opleiding van Tony di Pietro
Swinburne University of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GENETIC TECHNOLOGIES LIMITED | Health Technology |
ACRUX LIMITED | Health Technology |
INOVIQ LTD | Health Services |
Bedrijven in privébezit | 4 |
---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
Sienna Cancer Diagnostics Ltd.
Sienna Cancer Diagnostics Ltd. BiotechnologyHealth Technology Sienna Cancer Diagnostics Ltd. operates as a medical technology company. It delivers sensitive, novel, robust and test for early detection of cancer, assessment of cancer treatments and assistance in drug development. The company was founded in 2002 and is headquartered in Scoresby, Australia. | Health Technology |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Commercial Services |
BARD1AG SA
BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Health Services |